Dipan Mehta, Member at BSE & NSE is of the view that one may prefer Aurobindo Pharma, Cadila Healthcare and Torrent Pharmaceuticals from pharmaceutical space.
first published: Nov 16, 2015 01:47 pm
A collection of the most-viewed Moneycontrol videos.

Realty, PSU Banks Lead Nifty Back Near 25,800; Shriram Finance Scales Record High| Closing Bell Live

Will D-Street See A Sweet Start To November? Autos In Focus After Record Sales| Opening Bell Live

The Sikkim Girl Trying to Make it Big in Mumbai | Tenant

Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell
You are already a Moneycontrol Pro user.

